Abstract
This study uses commercial pharmaceutical database data to evaluate the number of new drugs and vaccines for neglected tropical diseases entering phase 1 clinical trials before and after introduction in 2007 of a priority review voucher program to incentivize development.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Clinical Trials, Phase I as Topic / statistics & numerical data
-
Drug Industry
-
Financing, Government
-
Humans
-
Orphan Drug Production / legislation & jurisprudence
-
Orphan Drug Production / statistics & numerical data*
-
Tropical Medicine*
-
United States